CUTRIGNELLI, ANNALISA
 Distribuzione geografica
Continente #
NA - Nord America 7.119
AS - Asia 3.174
EU - Europa 2.704
SA - Sud America 784
AF - Africa 115
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.911
Nazione #
US - Stati Uniti d'America 6.983
SG - Singapore 1.258
CN - Cina 790
IT - Italia 687
BR - Brasile 622
SE - Svezia 455
HK - Hong Kong 383
RU - Federazione Russa 311
FI - Finlandia 286
DE - Germania 251
VN - Vietnam 194
FR - Francia 180
GB - Regno Unito 172
UA - Ucraina 142
IN - India 105
BD - Bangladesh 85
CA - Canada 65
AR - Argentina 58
ID - Indonesia 52
IQ - Iraq 51
JP - Giappone 51
TR - Turchia 41
MX - Messico 40
ZA - Sudafrica 34
CI - Costa d'Avorio 33
PK - Pakistan 32
NL - Olanda 30
AT - Austria 27
EC - Ecuador 26
ES - Italia 26
BE - Belgio 25
VE - Venezuela 25
IE - Irlanda 22
PL - Polonia 21
CO - Colombia 19
CZ - Repubblica Ceca 16
MA - Marocco 15
SA - Arabia Saudita 15
LT - Lituania 13
AU - Australia 12
MY - Malesia 12
UZ - Uzbekistan 12
KR - Corea 10
PH - Filippine 10
PY - Paraguay 10
AZ - Azerbaigian 9
CL - Cile 9
IR - Iran 8
JO - Giordania 8
CH - Svizzera 7
EG - Egitto 7
ET - Etiopia 7
JM - Giamaica 7
BH - Bahrain 6
KZ - Kazakistan 6
RO - Romania 6
UY - Uruguay 6
NP - Nepal 5
PE - Perù 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
BY - Bielorussia 4
KE - Kenya 4
NI - Nicaragua 4
PT - Portogallo 4
AM - Armenia 3
DO - Repubblica Dominicana 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BB - Barbados 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
MK - Macedonia 2
MR - Mauritania 2
MU - Mauritius 2
NG - Nigeria 2
QA - Qatar 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CU - Cuba 1
DZ - Algeria 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
Totale 13.894
Città #
Ashburn 748
Singapore 689
Fairfield 650
Chandler 524
Woodbridge 437
Hong Kong 383
San Jose 380
Houston 373
Nyköping 341
Jacksonville 328
Seattle 298
Cambridge 284
Beijing 255
Wilmington 221
Ann Arbor 209
Helsinki 195
New York 189
Bari 171
Dallas 124
Los Angeles 112
Lawrence 109
Roxbury 106
Lauterbourg 97
Nanjing 92
Boardman 79
Des Moines 68
Brooklyn 66
Ho Chi Minh City 64
Princeton 62
São Paulo 53
Santa Clara 51
Bitonto 50
Council Bluffs 45
Hanoi 45
Grottaglie 44
Munich 41
Bitetto 40
Chicago 40
Jakarta 40
Buffalo 39
London 34
Abidjan 33
Shenyang 32
Napoli 31
Inglewood 30
San Diego 30
Frankfurt am Main 29
Tokyo 27
Brussels 25
Jiaxing 23
Tianjin 23
Baghdad 22
Dublin 22
Falkenstein 22
Hebei 22
Johannesburg 22
Nanchang 21
Orem 21
Denver 19
Montreal 19
Paris 19
Toronto 19
Amsterdam 18
San Francisco 18
Vienna 18
Warsaw 18
Milan 17
Turku 17
Changsha 16
Columbus 16
Moscow 16
Nuremberg 16
Washington 16
Atlanta 15
Guangzhou 15
Rio de Janeiro 15
Belo Horizonte 14
Chennai 14
Dong Ket 14
Mexico City 14
Stockholm 14
The Dalles 14
Guayaquil 13
Porto Alegre 13
Shanghai 13
Campinas 12
North Bergen 12
Toranomon 12
Wuhan 12
Elk Grove Village 11
Manchester 11
Poplar 11
Boston 10
Mumbai 10
Redwood City 10
Salt Lake City 10
Tashkent 10
Brasília 9
Brno 9
Falls Church 9
Totale 9.199
Nome #
S-preactivated thiolated glycol chitosan useful to combine mucoadhesion and drug delivery 314
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 288
Spray-dried mucoadhesives for intravesical drug delivery using N-acetylcysteine- and glutathione-glycol chitosan conjugates 249
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 243
Preactivated thiolated glycogen as mucoadhesive polymer for drug delivery 234
Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat 210
2-Phenylimidazo[1,2-a]pyridine-containing ligands of the 18-kDa translocator protein (TSPO) behave as agonists and antagonists of steroidogenesis in a mouse leydig tumor cell line. 208
A new complex of curcumin with sulfobutylether-β-cyclodextrin: characterization studies and in vitro evaluation of cytotoxic and antioxidant activity on HepG-2 cells 203
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 203
Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma 194
Delivery of proapoptotic agents in glioma cell lines by TSPO ligand–dextran nanogels 188
A Novel PET Imaging Probe for the Detection and Monitoring of Translocator Protein 18 kDa Expression in Pathological Disorders 185
Bcr-abl tyrosine kinase inhibitors in the treatment of pediatric cml 184
A histochemical approach to glycan diversity in the urothelium of pig urinary bladder 180
Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. 180
Drug delivery nanovectors based on SPIONS for targeted therapy of hepatocellular carcinoma 179
Taste masking of propranolol hydrochloride by microbeads of EUDRAGIT® E PO obtained with prilling technique for paediatric oral administration 179
Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment 173
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. 170
Oxazepam-Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats 170
Imaging modification of colon carcinoma cells exposed to lipid based nanovectors for drug delivery: a scanning electron microscopy investigation 164
TSPO ligand-methotrexate prodrug conjugates: Design, synthesis, and biological evaluation 160
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 160
Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases 156
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing glutathione 152
Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers 151
The hydroxypropyl‐β‐cyclodextrin‐minoxidil inclusion complex improves the cardiovascular and proliferative adverse effects of minoxidil in male rats: Implications in the treatment of alopecia 148
Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate 147
b-Cyclodextrin in personal care formulation: role on the complexation of malodors causing molecules 145
Transferrin Functionalized Liposomes Loading Dopamine HCl: Development and Permeability Studies across an In Vitro Model of Human Blood-Brain Barrier 139
Characterization and release studies of liposomal gels containing glutathione/cyclodextrins complexes potentially useful for cutaneous administration 139
B-CYCLODEXTRIN IN PERSONAL CARE FORMULATION: ROLE ON THE COMPLEXATION OF MALODORS CAUSING MOLECULES 138
Colonic budesonide delivery by multistimuli alginate/Eudragit® FS 30D/inulin-based microspheres as a paediatric formulation 137
Spray-dried mucoadhesive microparticles based on S-protected thiolated hydroxypropyl-β-cyclodextrin for budesonide nasal delivery 136
Pharmaceutical development of novel lactate-based 6-fluoro-L-DOPA formulations 131
Single-dose extended-toxicity preclinical study on novel radiotracer formulations for use in the diagnosis of neuroendocrine tumor and neurodegenerative disorders 128
Comparative effect of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 127
Translocator Protein Ligand-PLGA conjugates nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells 126
From oil to microparticulate by prilling technique: Production of polynucleate alginate beads loading Serenoa Repens oil as intestinal delivery systems 125
Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery 123
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 121
Hydroxy-propil-β-cyclodextrin inclusion complexes of two biphenylnicotinamide derivatives: Formulation and anti-proliferative activity evaluation in pancreatic cancer cell models 121
Synthesis, characterization, and in vitro evaluation of a new TSPO-selective bifunctional chelate ligand 120
PEGylated solid lipid nanoparticles for brain delivery of lipophilic kiteplatin Pt(IV) prodrugs: An in vitro study 119
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer 118
Magnetic implants in vivo guiding sorafenib liver delivery by superparamagnetic solid lipid nanoparticles 118
beta-Cyclodextrin in personal care formulation: role on the complexation of malodours causing molecules 117
Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations 117
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 116
Nanoparticelle a base di Eudragit® RS 100 contenenti ciclodestrine utili per la somministrazione transmucosale di Glutatione 116
Griseofulvin/carrier blends: application of partial least squares (PLS) regression analysis for estimating the factors affecting the dissolution efficiency. 115
Thiolated hydroxypropyl-β-cyclodextrin as mucoadhesive excipient for oral delivery of budesonide in liquid paediatric formulation 115
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 113
Comparative study of gels containing a minoxidil/MebCD complex with conventional formulation 113
Natural dendrimers: Synthesis and in vitro characterization of glycogen-cysteamine conjugates 113
The use of Eudragit RS100/cyclodextrin nanoparticles for the transmucosal administration of glutathione 110
Combined Eudragit RS100 cyclodextrin nanoparticles intended for transmucosal administration of Glutathione 108
Chitosan- And Glycolchitosan-Based Nanoparticles For Methotrexate Administration Across The Blood Brain Barrier 107
β-cyclodextrin in personal care formulations: role on the complexation of malodours causing molecules 107
Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease 107
Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice 105
Direct cyclodextrin-based powder extrusion 3D printing for one-step production of the BCS class II model drug niclosamide 105
Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies 102
Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs 101
Stability data of extemporaneous suspensions of hydroxychloroquine sulphate in oral liquid bases after tablet manipulation 101
In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM–FITC labeled dendrimer 100
New ethanol and propylene glycol free gel formulations containing a minoxidil-methyl-β-cyclodextrin complex as promising tools for alopecia treatment 100
COLD KITS BASED ON PSMA LIGANDS FOR THE PREPARATION OF RADIOPHARMACEUTICALS 99
COMPARATIVE STUDY OF GELS CONTAINING A MINOXIDIL/MEbCD COMPLEX WITH CONVENTIONAL FORMULATIONS 99
Griseofulvin/carrier blends: identification of factors affecting the dissolution efficiency of solid dispersions using carrier molecular descriptors and Partial Least-Squares (PLS) regression analysis 99
DEVELOPMENT OF MUCOADHESIVE MICROSPHERES AS CELECOXIB DELIVERY SYSTEMS IN THE BLADDER 99
Reproducibility warning: The curious case of polyethylene glycol 6000 and spheroid cell culture 99
Development of purified glycogen derivatives as siRNA nanovectors 98
New nanostructured self-assemblong inulin-a-tocopherol bioconjugates for biomedical applications 96
Microfluidic preparation and in vitro evaluation of iRGD-functionalized solid lipid nanoparticles for targeted delivery of paclitaxel to tumor cells 96
Investigating the prilling/vibration technique to produce gastric-directed drug delivery systems for misoprostol 95
Relationship between dissolution efficiency of Oxazepam/carrier blends and drug and carrier molecular descriptors using multivariate regression analysis 94
Effect of cyclodextrins on physico-chemical and release properties of Eudragit RS 100 microparticles containing Glutathione 92
null 92
Preparation of cetyl palmitate-based PEGylated solid lipid nanoparticles by microfluidic technique 91
NEW ETHANOL-FREE FORMULATIONS CONTAINING A MINOXIDIL/METHYL-b-CICLODEXTRIN COMPLEX IN ALOPECIA TREATMENT 89
Effectiveness of a controlled 5-fu delivery based on fzd10 antibody-conjugated liposomes in colorectal cancer in vitro models 89
Solid lipid nanoparticles as a novel delivery system for the antioxidant glutathione 88
NEW BIODEGRADABLE HYDROGELS DESIGNED FOR COLONIC DRUG DELIVERY: IN VITRO RELEASE OF THE PEPTIDES GLUTATHIONE AND OXYTOCIN 87
Morphology loading and release properties of poly(D,L-lactide-co-glycolide) microparticles containing the hypnotic agent etizolam 86
Effects of different cyclodextrins on the morphology, loading and release properties of poly(DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam. 86
Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment 85
Valproic acid hydrophilic cyclodextrin complexes and valproic acid-solid 85
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 84
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism 83
SYNTHESIS, CHARACTERIZATION AND CELLULAR INTERNALIZATION OF TSPO TARGETED G(4)-PAMAM DENDRIMERS INTO C6 RAT GLIOMA CELLS. 82
Comparative study among some potential dermal formulations intended for glutathione administration 82
Complexation of phenytoin with some hydrophilic ciclodextrins: effect on aqueous solubilità, dissolution rate, and anticonvulsant activity in mice 82
Highly selective luminescent nanostructures for mitochondrial imaging and targeting 82
SPRAY DRIED MICROPARTICLES OF CHITOSAN OR ITS THIOLIC DERIVATES FOR CELECOXIB INTRAVESCICAL DELIVERY 80
NEW NANOSTRUCTURED SELF-ASSEMBLING INULIN-α-TOCOPHEROL BIOCONJUGATES FOR BIOMEDICAL APPLICATION 79
Design and synthesis of grafted TSPO ligand-amino functionalized silica-coated quantum dots 79
Preparation and characterization of gels containing a minoxidil /MebCD complex for cutaneous delivery in alopecia 78
Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis 77
TARGETING THE MITOCHONDRIAL PROTEIN (TSPO) THROUGH G(4)-PAMAM DENDRIMERS 76
Totale 12.879
Categoria #
all - tutte 57.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.955


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 0 0 0 0 0 0 0 63
2021/2022960 63 90 7 19 35 85 48 35 80 123 140 235
2022/20231.474 217 193 107 124 162 190 29 160 215 21 39 17
2023/2024711 36 107 40 40 79 201 59 53 10 13 20 53
2024/20252.468 95 47 197 87 103 223 326 223 61 111 345 650
2025/20264.633 723 244 354 522 505 275 576 185 563 464 174 48
Totale 14.249